Directory
>
Angelico Carta
Angelico Carta
President | Worldwide Clinical Trials
England, United Kingdom
Angelico Carta
Summary
Dr. Angelico Carta is a seasoned leader in the pharmaceutical and clinical research sectors, currently serving as the President and co-founder of Worldwide Clinical Trials. With over 25 years of experience, he has successfully guided the company from its inception in 1996 to a prominent global player in drug development services. Dr. Carta has a proven track record of strategic growth, expanding operations across Europe and into emerging markets such as MENA and AsiaPacific. His expertise encompasses a wide array of areas, including clinical development, regulatory affairs, and pharmacovigilance. An accomplished author, he has contributed to over 30 publications in clinical neuropsychopharmacology and co-authored several reference texts on CNS drug development. Dr. Carta's academic background includes an MD from the University of Rome and specialization in Neurology from King's College Hospital in London. His visionary leadership and commitment to patient-focused research continue to drive innovation in the industry.
Angelico Carta
Work Experience
President at
Worldwide Clinical Trials
January 2007 - Present
Frequently Asked Questions about Angelico Carta
What is Angelico Carta email address?
Angelico Carta's primary email address is **************@wwctrials.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Angelico Carta work for?
Angelico Carta is a President at Worldwide Clinical Trials, a company specializing in Commercial physical research.
How can I directly contact Angelico Carta?
To contact Angelico Carta directly, you can use the email address **************@wwctrials.com. Complete contact information is available upon registration with Muraena.
Who is Angelico Carta?
Dr. Angelico Carta is a seasoned leader in the pharmaceutical and clinical research sectors, currently serving as the President and co-founder of Worldwide Clinical Trials. With over 25 years of experience, he has successfully guided the company from its inception in 1996 to a prominent global player in drug development services. Dr. Carta has a proven track record of strategic growth, expanding operations across Europe and into emerging markets such as MENA and AsiaPacific. His expertise encompasses a wide array of areas, including clinical development, regulatory affairs, and pharmacovigilance. An accomplished author, he has contributed to over 30 publications in clinical neuropsychopharmacology and co-authored several reference texts on CNS drug development. Dr. Carta's academic background includes an MD from the University of Rome and specialization in Neurology from King's College Hospital in London. His visionary leadership and commitment to patient-focused research continue to drive innovation in the industry.
Angelico`s contact details
**************@wwctrials.com
**************@worldwide.com
Colleagues
SVP Planning & Project Administration, Head of Technologies
CEO & Board Member
Senior Vice President, Medical Sciences
Executive Director, Clinical Operations, Latin America Head
Vice President Business Development
Vice President Project Management, Oncology
Executive Director, Therapeutuc Strategy Lead, Neuroscience
Senior Vice President, Project Management - Neuroscience
Executive Director, Site Relationships and Decentralized Clinical Trials
Executive Director, Project Management